TR200200673T2 - Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması - Google Patents

Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması

Info

Publication number: TR200200673T2
Authority: TR; Turkey
Prior art keywords: csaids; rhinovirus infections; rhinovirus; infections; symptoms
Prior art date: 1999-09-17

Application number

TR2002/00673T

Other languages

English (en)

Turkish (tr)

Inventor

B. Dillon Susan

D. Griego Sandra

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-17

Filing date

2000-09-15

Publication date

2002-12-23

2000-09-15 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2002-12-23 Publication of TR200200673T2 publication Critical patent/TR200200673T2/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

TR2002/00673T 1999-09-17 2000-09-15 Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması TR200200673T2 (tr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US15449499P	1999-09-17	1999-09-17

Publications (1)

Publication Number	Publication Date
TR200200673T2 true TR200200673T2 (tr)	2002-12-23

Family

ID=22551566

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2002/00673T TR200200673T2 (tr)	1999-09-17	2000-09-15	Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması

Country Status (17)

Country	Link
EP (1)	EP1223924A4 (xx)
JP (1)	JP2003516314A (xx)
KR (1)	KR20020032591A (xx)
CN (1)	CN1382044A (xx)
AR (1)	AR025691A1 (xx)
AU (1)	AU7584500A (xx)
BR (1)	BR0014041A (xx)
CA (1)	CA2385722A1 (xx)
CO (1)	CO5200855A1 (xx)
CZ (1)	CZ2002939A3 (xx)
HU (1)	HUP0204333A3 (xx)
IL (1)	IL148329A0 (xx)
NO (1)	NO20021301L (xx)
PL (1)	PL363116A1 (xx)
TR (1)	TR200200673T2 (xx)
WO (1)	WO2001019322A2 (xx)
ZA (1)	ZA200202060B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
JP2002528506A (ja)	1998-11-04	2002-09-03	スミスクライン・ビーチャム・コーポレイション	ピリジン−４−イルまたはピリミジン−４−イル置換ピラジン
AU1783201A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
JP2003514899A (ja)	1999-11-23	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４‐ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
DE60023025T2 (de)	1999-11-23	2006-07-13	Smithkline Beecham Corp.	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
JP2004530648A (ja) *	2000-10-19	2004-10-07	スミスクライン・ビーチャム・コーポレイション	炎症により促進される咳の治療のためのｐ３８阻害剤の使用
IL155367A0 (en)	2000-10-23	2003-12-23	Smithkline Beecham Corp	NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES
AU2003230692A1 (en) *	2002-03-20	2003-10-08	Elan Pharma International Ltd.	Nanoparticulate compositions of map kinase inhibitors
WO2003084503A2 (en) *	2002-04-05	2003-10-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	P38 kinase inhibitors for treating mucus hypersecretion_
DE60310730T2 (de) *	2002-07-09	2007-05-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
JP4593953B2 (ja) *	2004-03-30	2010-12-08	杏林製薬株式会社	ライノウイルス感染症の予防薬
WO2006017505A2 (en) *	2004-08-04	2006-02-16	Schering Corporation	Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
PE20100737A1 (es)	2005-03-25	2010-11-27	Glaxo Group Ltd	Nuevos compuestos
WO2009116944A1 (en) *	2008-03-20	2009-09-24	Krister Tano	Use of a substance for manufacturing of a medicament for treatment of common cold
GB0905955D0 (en)	2009-04-06	2009-05-20	Respivert Ltd	Novel compounds
CN102573886A (zh) *	2009-09-17	2012-07-11	相互制药公司	用抗病毒剂治疗哮喘的方法
GB201010196D0 (en) *	2010-06-17	2010-07-21	Respivert Ltd	Methods
GB201010193D0 (en) *	2010-06-17	2010-07-21	Respivert Ltd	Medicinal use
US11730760B2 (en)	2011-04-01	2023-08-22	The Bioregentech Institute, Inc.	Laser assisted wound healing protocol and system
US11389663B2 (en)	2011-04-01	2022-07-19	Bioregentech, Inc.	Laser assisted wound healing protocol and system
GB201611712D0 (en)	2016-07-02	2016-08-17	Hvivo Services Ltd	Methods and compounds for the treatment or prevention of severe or persistent influenza
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt)	2017-10-05	2022-10-06	Fulcrum Therapeutics Inc	Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
GB201721793D0 (en) *	2017-12-22	2018-02-07	Hvivo Services Ltd	Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza
WO2021216754A1 (en) *	2020-04-21	2021-10-28	Spring Discovery, Inc.	Use of p38 mapk inhibitors for prevention and treatment of aging and aging-related disorders and for boosting an immune system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3927216A (en) *	1971-06-01	1975-12-16	Icn Pharmaceuticals	1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US3984396A (en) *	1971-06-01	1976-10-05	Icn Pharmaceuticals, Inc.	1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US5656644A (en) *	1994-07-20	1997-08-12	Smithkline Beecham Corporation	Pyridyl imidazoles
US5658903A (en) *	1995-06-07	1997-08-19	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
AP9700912A0 (en) *	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
WO2000040243A1 (en) *	1999-01-08	2000-07-13	Smithkline Beecham Corporation	Novel compounds

2000
- 2000-09-15 WO PCT/US2000/025386 patent/WO2001019322A2/en not_active Ceased
- 2000-09-15 CN CN00813012A patent/CN1382044A/zh active Pending
- 2000-09-15 CA CA002385722A patent/CA2385722A1/en not_active Abandoned
- 2000-09-15 TR TR2002/00673T patent/TR200200673T2/xx unknown
- 2000-09-15 KR KR1020027003518A patent/KR20020032591A/ko not_active Withdrawn
- 2000-09-15 CO CO00070099A patent/CO5200855A1/es not_active Application Discontinuation
- 2000-09-15 AU AU75845/00A patent/AU7584500A/en not_active Abandoned
- 2000-09-15 CZ CZ2002939A patent/CZ2002939A3/cs unknown
- 2000-09-15 JP JP2001522960A patent/JP2003516314A/ja not_active Withdrawn
- 2000-09-15 EP EP00965060A patent/EP1223924A4/en not_active Withdrawn
- 2000-09-15 HU HU0204333A patent/HUP0204333A3/hu unknown
- 2000-09-15 PL PL00363116A patent/PL363116A1/xx not_active Application Discontinuation
- 2000-09-15 IL IL14832900A patent/IL148329A0/xx unknown
- 2000-09-15 BR BR0014041-4A patent/BR0014041A/pt not_active IP Right Cessation
- 2000-09-17 AR ARP000104866A patent/AR025691A1/es not_active Application Discontinuation
2002
- 2002-03-13 ZA ZA200202060A patent/ZA200202060B/en unknown
- 2002-03-15 NO NO20021301A patent/NO20021301L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ2002939A3 (cs)	2002-11-13
CN1382044A (zh)	2002-11-27
EP1223924A2 (en)	2002-07-24
AR025691A1 (es)	2002-12-11
NO20021301D0 (no)	2002-03-15
WO2001019322A2 (en)	2001-03-22
EP1223924A4 (en)	2004-07-14
NO20021301L (no)	2002-05-16
BR0014041A (pt)	2003-07-15
CA2385722A1 (en)	2001-03-22
HUP0204333A3 (en)	2004-07-28
HUP0204333A2 (en)	2003-05-28
AU7584500A (en)	2001-04-17
JP2003516314A (ja)	2003-05-13
KR20020032591A (ko)	2002-05-03
ZA200202060B (en)	2003-05-28
CO5200855A1 (es)	2002-09-27
IL148329A0 (en)	2002-09-12
WO2001019322A3 (en)	2001-10-04
PL363116A1 (en)	2004-11-15

Publication	Publication Date	Title
TR200200673T2 (tr)	2002-12-23	Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
TR199802693T2 (xx)	1999-05-21	De�i�tirilmi� 3,5-difenil-1,2,4-triazoller ve eczasal metal kelatorlar olarak kullan�m�.
TR200000928T2 (tr)	2000-11-21	Yeni kombinasyon.
TR200100805T2 (tr)	2001-08-21	Tetrahidropiridoeterler
DK0970095T3 (da)	2004-03-08	Hidtil ukendte benzimidazolinhibitorer for fructose-1,6-bisphosphase
TR200201364T2 (tr)	2002-10-21	Yeni bileşikler.
ES2154741T3 (es)	2001-04-16	Uso de agentes de union a cd23 en el tratamiento de enfermedades autoinmunes.
TR199700732T1 (xx)	1998-02-21	�nsan l�kosit elastazinin inhibit�rleri olarak yararl� olan prolin t�revleri.
TR200002860T2 (tr)	2000-12-21	Bir antiviral benzimidazol terkibin yeni kristal formları.
WO1999020260A3 (en)	2000-03-09	The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
TR200001040T2 (tr)	2001-01-22	Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
DE60013486D1 (de)	2004-10-07	Verbindungen
TR199800841A2 (xx)	1998-12-21	�kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
BR0012675A (pt)	2002-04-09	Uso de inibidores de il-18
DE69531459D1 (de)	2003-09-11	Elatase-inhibitoren
MY136261A (en)	2008-09-30	Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
TR200103237T2 (tr)	2002-04-22	İmidazodiazepin türevi
RU2001120358A (ru)	2005-12-10	Применение ингибиторов натрий-водород-антипортера для получения лекарственного средства для ингибирования обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
DE69316417D1 (de)	1998-02-26	Reduzierung des Stromverbrauches in Mikroprozessoren
TR199802270A2 (xx)	1999-05-21	S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
DE69838686D1 (de)	2007-12-20	Tripeptidylpeptidaseinhibitoren
FR2765214B1 (fr)	2003-10-17	Traitement de granulat par un latex anti-desenrobage
DE60018192D1 (de)	2005-03-24	Behandlung von konjunktivitis mit histacalin proteinen
TR199701605A2 (xx)	1998-07-21	S�lfonamid-substit�e edilmi� bile�ikler
BR0009289A (pt)	2002-01-22	Uso de inibidores da vasopeptidase para tratar angina pectoris